Monopoly of DRUG price-controls by TPP
From: Martyn & Steph -NZ
The Trans-Pacific Partnership is the most secretive and "least transparent" trade negotiations in history
The Council of Canadians and OpenMedia, major campaigners for Internet freedom, have warned that the TPP would "criminalize some everyday uses of the Internet," including music downloads as well as the combining of different media works. OpenMedia warned that the TPP would "force service providers to collect and hand over your private data without privacy safeguards, and give media conglomerates more power to send you fines in the mail, remove online content - including entire websites - and even terminate your access to the Internet."
Pharmaceutical corporations are major proponents of these rights and are likely to be among the major beneficiaries of the intellectual property chapter of the TPP. The pharmaceutical industry ensured that strong patent rules were included in the 1995 World Trade Organization agreement, but ultimately felt that those rules did not go far enough.
Essentially, what this means is that in poor countries where more people need access to life-saving drugs, and at cheaper cost, it would be impossible for companies or governments to manufacture and sell cheaper generic brands of successful drugs held by multinational corporate patents. Such an agreement would hand over a monopoly of price-controls to these corporations, allowing them to set the prices as they deem fit, thus making the drugs incredibly expensive and often inaccessible to the people who need them most.
The Trans-Pacific Partnership is the most secretive and "least transparent" trade negotiations in history
The Council of Canadians and OpenMedia, major campaigners for Internet freedom, have warned that the TPP would "criminalize some everyday uses of the Internet," including music downloads as well as the combining of different media works. OpenMedia warned that the TPP would "force service providers to collect and hand over your private data without privacy safeguards, and give media conglomerates more power to send you fines in the mail, remove online content - including entire websites - and even terminate your access to the Internet."
Pharmaceutical corporations are major proponents of these rights and are likely to be among the major beneficiaries of the intellectual property chapter of the TPP. The pharmaceutical industry ensured that strong patent rules were included in the 1995 World Trade Organization agreement, but ultimately felt that those rules did not go far enough.
Essentially, what this means is that in poor countries where more people need access to life-saving drugs, and at cheaper cost, it would be impossible for companies or governments to manufacture and sell cheaper generic brands of successful drugs held by multinational corporate patents. Such an agreement would hand over a monopoly of price-controls to these corporations, allowing them to set the prices as they deem fit, thus making the drugs incredibly expensive and often inaccessible to the people who need them most.
Comments
Post a Comment